We analyze price and quality competition in a mixed duopoly in which a profit-maximizing
private firm competes against a state-owned public firm. We first show that the welfare …

Without spillovers and under the 'winner-take-all'hypothesis, there is overinvestment in R &
D in a non-cooperative equilibrium due to duplication of effort. We show that a public firm …

We study a multistage, quality-then-price game between a public firm and a private firm. The
market consists of a set of consumers who have different quality valuations. The public firm …

One of the mechanisms that are implemented in the cost containment movement in the
health care sectors in western countries is the definition, by the third‐party payer, of a set of …

We develop a mixed oligopoly model with one public firm and two private firms to explore
the licensing strategy considered by the innovated private firm. The major findings of our …

This paper studies the interaction of private and public health care providers. I present a
model, which acknowledges that consumers differ in their income levels. Health care is …

We examine oligopoly models of vertical product differentiation in which producing firms
face variable costs of quality development. We show that comparing to private oligopoly …

Research in Health Economics has developed into a separate discipline for the last 25
years. All this intense research activity, has translated in the inclusion of courses of health …

In the framework of a vertically differentiated mixed duopoly, with uncovered market and
zero costs, we study the existence of a price equilibrium when a welfare-maximizing public …

The paper studies duopolistic competition when firms face fixed quality‐dependent costs of
production and one of the two firms targets (at least in the long run) welfare maximization …